Capital Research Global Investors
HOLX

Capital Research Global Investors’s Hologic HOLX Stock Holding History

Capital Research Global Investors’s Portfolio HOLX Stock Details HOLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-394
Closed -$20K – 413
2019
Q3 		$20K Sell
394
-6,384,747
-100% -$314M ﹤0.01% 414
2019
Q2 		$307M Sell
6,385,141
-2,673,279
-30% -$124M 0.1% 169
2019
Q1 		$438M Sell
9,058,420
-3,466,269
-28% -$156M 0.14% 147
2018
Q4 		$515M Sell
12,524,689
-2,448,047
-16% -$100M 0.18% 116
2018
Q3 		$614M Sell
14,972,736
-3,587,628
-19% -$145M 0.18% 118
2018
Q2 		$738M Buy
18,560,364
+1,942
+0% +$74.7K 0.2% 115
2018
Q1 		$693M Buy
18,558,422
+1,375,997
+8% +$55.6M 0.2% 117
2017
Q4 		$735M Buy
17,182,425
+8,125,405
+90% +$324M 0.22% 111
2017
Q3 		$332M Hold
9,057,020
– – 0.1% 170
2017
Q2 		$411M Sell
9,057,020
-1,517,480
-14% -$67M 0.13% 154
2017
Q1 		$450M Sell
10,574,500
-3,041,859
-22% -$124M 0.14% 152
2016
Q4 		$546M Sell
13,616,359
-3,687,895
-21% -$142M 0.18% 132
2016
Q3 		$672M Sell
17,304,254
-5,146,659
-23% -$194M 0.22% 118
2016
Q2 		$777M Sell
22,450,913
-2,984,627
-12% -$103M 0.27% 102
2016
Q1 		$878M Sell
25,435,540
-454,445
-2% -$15.8M 0.3% 90
2015
Q4 		$1B Sell
25,889,985
-3,946,300
-13% -$154M 0.34% 77
2015
Q3 		$1.17B Sell
29,836,285
-4,516,655
-13% -$179M 0.42% 63
2015
Q2 		$1.31B Buy
34,352,940
+59,000
+0.2% +$2.07M 0.43% 63
2015
Q1 		$1.13B Buy
34,293,940
+268,795
+0.8% +$8.25M 0.39% 72
2014
Q4 		$910M Buy
34,025,145
+418,000
+1% +$10.8M 0.31% 85
2014
Q3 		$818M Hold
33,607,145
– – 0.28% 91
2014
Q2 		$852M Buy
33,607,145
+480,600
+1% +$11.2M 0.3% 95
2014
Q1 		$712M Hold
33,126,545
– – 0.26% 111
2013
Q4 		$740M Buy
33,126,545
+151,000
+0.5% +$3.33M 0.27% 105
2013
Q3 		$681M Buy
32,975,545
+329,300
+1% +$7.01M 0.27% 103
2013
Q2 		$630M Buy
+32,646,245
New +$682M 0.27% 107

Other funds holding HOLX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Capital Research Global Investors's HOLX Position: Q4 2019 in Review

Capital Research Global Investors sold out of Hologic (HOLX) in Q4 2019, closing a stake of 394 shares — an estimated $20K sold.

Capital Research Global Investors first reported a position in HOLX in Q2 2013 and held it in 26 quarters. The position peaked at $1.31B in Q2 2015. 520 funds tracked by Wall St. Rank hold HOLX as of Q4 2019.

  • Capital Research Global Investors reported no remaining Hologic position as of Q4 2019 after selling out during the quarter.
  • Capital Research Global Investors sold 394 Hologic shares in Q4 2019, an estimated $20K.
  • Capital Research Global Investors first reported a position in Hologic in Q2 2013 and held it in 26 quarters.
  • Capital Research Global Investors's Hologic position peaked at $1.31B in Q2 2015.
  • 520 funds tracked by Wall St. Rank held Hologic as of Q4 2019.

Based on Capital Research Global Investors's 13F filing for Q4 2019, filed 18 Feb 2020.